| Expression of c-kit proto-oncogene product in breast cancer tissues. | breast, |
| KIT regulates tyrosine phosphorylation and nuclear localization of beta-catenin in mast cell leukemia. | leukemia, |
| C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma. | skin, |
| C-kit protein expression correlated with activating mutations indicating the pertinent role of the proto-oncogene KIT in the tumorigenesis of oral musosal melanoma. | skin, |
| Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia. | leukemia, |
| Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression. | skin, |
| Imatinib targeting of KIT-mutant oncoprotein in melanoma. | skin, |
| c-KIT signaling as the driving oncogenic event in sub-groups of melanomas. | skin, |
| Amplification of chromosomal segment 4q12 in non-small cell lung cancer. | lung, |
| Observations implicate PDGFRA and KIT as potential oncogenes in NSCLC. | lung, |
| A Variant in a MicroRNA complementary site in the 3 UTR of the KIT oncogene increases risk of acral melanoma. | skin, |
| describe a genetic variant in the 3_ UTR of the KIT oncogene that correlates with a greater than fourfold increased risk of acral melanoma | skin, |
| MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia. | leukemia, |
| A substantial portion of mucosal melanomas carry a therapeutically relevant mutation in the KIT oncogene. | skin, |
| Expression of proto-oncogene KIT is up-regulated in subset of human meningiomas. | meningiomas, |
| Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT. | leukemia, |
| Data from mutant and heterozygote mice suggest that balance between Fas and c-Kit (proto-oncogene c-kit) signaling is critical in pancreatic beta-cell survival and function; diabetes develops early in mice without Fas and c-Kit. | pancreatic, |
| Our study indicates to specify the role of c-kit proto-oncogene mutation in breast cancer. | breast, |
| Data indicate that proto-oncogene protein Kit(w-sh) mice showed an unaltered capacity to develop lung pathology and increased mucus production in response to house dust mite (HDM). | lung, |
| KIT oncogene inhibition drives intratumoral macrophage M2 polarization. | oral |